This item requires a subscription to Diabetes Care.
Full Text (PDF)
Original Research - Emerging Treatments & Technologies:
John P.H. Wilding,
Paul Norwood,
Caroline T'joen,
Arnaud Bastien,
James F. List,
and Fred T. Fiedorek
A Study of Dapagliflozin in Patients With Type 2 Diabetes Receiving High Doses of Insulin Plus Insulin Sensitizers: Applicability of a novel insulin-independent treatment Diabetes Care September 2009 32:1656-1662; published ahead of print June 15, 2009, doi:10.2337/dc09-0517